Bioprocess International Europe

Format :

On-site

The aim of this meeting is to :

• Engage with CMC directors and pipeline leaders for antibodies/ADCs to offer tailored analytical development services (e.g., bioassays, HCP quantification, aggregation analysis).
• Identify scale-up needs for mAbs, ADCs, and recombinant proteins, and position a comprehensive GMP offering across upstream and downstream processing.
• Monitor emerging trends in bioconjugation and complex formulation technologies, such as lyophilization strategies for unstable proteins.
• Promote a proprietary or differentiated biomanufacturing platform, including cell line development, media optimization, and intensified processes like perfusion.

Communication and dissemination tools :

• Stands
• Kakemonos
• Workshops